LMP350H1 - Introduction to Pathobiology II

Course description

Molecular basis of tissue repair and fibrosis, endocrine and signaling disorders, introduction to neurodegenerative diseases.

Animal models and genetic basis of disease.

Mechanisms infection by virus, bacteria and parasites.

Topics are chosen to complement LMP340H1 and introduce areas that may be explored in more depth in 400-level LMP courses.

Course coordinator

Dr Doug Templeton

Office address: 1 King’s College Circle, MSB 6275

doug.templeton@utoronto.ca

Teaching assistant

Yuki Leung

ysl.leung@mail.utoronto.ca

 

Term Winter 2021  
Class location and time

Wednesday 9:00-11:00 am

Online Synchronous

Tutorial location and time

Wednesday 11:00-12:00pm

Online Synchronous

Office hours Contact TA or instructors

Course details

  • Hours: 24L/12T
  • Prerequisite information: Enrolment is limited to students specialized in Pathobiology who have completed, or are completing, the first and second year requirements of the program.
  • Prerequisite: LMP340H1
  • Exclusions: LMP300Y1, LMP301H1, LMP363H1
  • Distribution requirements: Science
  • Breadth requirement: Living Things and Their Environment (4)
  • Enrolment limits: 40 students

Student evaluation

Term test (multiple choice), Feb. 24 – 20 %

Assignment, Due March 26 – 40 %

Final exam (weighted cumulative), April 2021 – 40 %

See information on Academic Integrity

Schedule - Winter 2021

Date Title Instructor
January 6, 2021 Biomedical genetics I David Irwin
January 13, 2021 Biomedical genetics II David Irwin
January 20, 2021 ECM I: Fibrosis and repair Mohit Kapoor
January 27, 2021 ECM II: MSCs and ECM remodeling Viswanathan
February 3, 2021 Animal models Susan Camilleri
February 10, 2021 Viruses Jeffrey Lee
February 17, 2021 Reading week  
February 24, 2021 Term test/assignment discussion Doug Templeton
March 3, 2021 Bacteria Jeffrey Lee
March 10, 2021 Parasites Jeffrey Lee
March 17, 2021 Pathobiology of Steroidogenesis Gershon
March 24, 2021 Metabolic and endocrine disorders I Harry Elsholtz
March 31, 2021 Metabolic and endocrine disorders II Harry Elsholtz